Researchers at universities across California and companies, such as New York-based Precision Neuroscience, are among those making headway towards generating naturalistic speech through a combination ...

Over the last couple of decades, many people have regained hearing functionality with the most successful neurotech device to ...

The Food and Drug Administration on Thursday cleared a core component of a brain implant made by Precision Neuroscience, a ...

Learn more in the Marathon Gameplay Overview video! If you’re looking for a deeper dive into Marathon’s gameplay, peep the overview narrated by none other than Ben Starr. This overview goes into more ...

Become a runner in Marathon, a sci-fi PvP extraction shooter as you compete for survival, riches, and renown in a world of evolving, persistent zones, where any run can lead to greatness.

She is a ruthless "razorgirl" (street samurai) with augmented reflexes and cybernetic implants, including razor-sharp retractable blades underneath her fingernails and vision-enhancing mirrored ...

Musk announced on X that Neuralink was seeking a second participant for its brain-computer interface human trials. He described the technology as a "telepathy cybernetic brain implant that allows you ...

Neuralink’s goal is to create a direct interface between humans and artificial intelligence ... Those skeptical of brain implants might recall Musk’s earlier promises about a “telepathy cybernetic ...

Elon Musk ‘Blindsight’ chip Implant: Elon Musk said his brain chip startup Neuralink aims to have its artificial visual prosthesis, Blindsight, implanted in a human for the first time by the end of ...

is currently the global leader in terms of human trials with 10 patients, six in the United States and four in Australia. Musk's Neuralink currently has three people with its implant. Neuralink is ...

Elon Musk’s Neuralink to implant its Blindsight chip in first human in 2025 The chip is aimed to restore vision even in people who have lost both eyes The Blindsight chip received US FDA approval in ...